Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of cancer therapy by inhibiting fusion polypeptides comprising fibroblast growth factor receptor 2 (FGFR2) and vinculin (VCL)

Methods of cancer therapy by inhibiting fusion polypeptides comprising fibroblast growth factor receptor 2 (FGFR2) and vinculin (VCL)

US Patent 10703798 · Granted Jul 7, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer2024
Benzisoxazole derivative2022
CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer2022
Tetrahydroisoquinoline derivatives2022
Pyridine compound substituted with azole2022
2-acylaminothiazole derivative or salt thereof2022
CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer2021
Tetrahydroisoquinoline derivatives2020
Tetrahydroisoquinoline derivatives2019
2-acylaminothiazole derivative or salt thereof2018
Tetrahydroisoquinoline derivatives2018
2-aminothiazole derivative or salt thereof2017